A very rare cancer in Down Syndrome: medulloblastoma. Epidemiological data from 13 countries
Standard
A very rare cancer in Down Syndrome: medulloblastoma. Epidemiological data from 13 countries. / Satgé, Daniel; Stiller, Charles A; Rutkowski, Stefan; von Bueren, André O; Lacour, Brigitte; Sommelet, Danièle; Nishi, Motoi; Massimino, Maura; Garré, Maria Luisa; Moreno, Florencia; Hasle, Henrik; Jakab, Zsuzsanna; Greenberg, Mark; von der Weid, Nicolas; Kuehni, Claudia; Zurriaga, Oscar; Vicente, Maria-Luisa; Peris-Bonet, Rafael; Benesch, Martin; Vekemans, Michel; Sullivan, Sheena G; Rickert, Christian.
in: J NEURO-ONCOL, Jahrgang 112, Nr. 1, 01.03.2013, S. 107-14.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A very rare cancer in Down Syndrome: medulloblastoma. Epidemiological data from 13 countries
AU - Satgé, Daniel
AU - Stiller, Charles A
AU - Rutkowski, Stefan
AU - von Bueren, André O
AU - Lacour, Brigitte
AU - Sommelet, Danièle
AU - Nishi, Motoi
AU - Massimino, Maura
AU - Garré, Maria Luisa
AU - Moreno, Florencia
AU - Hasle, Henrik
AU - Jakab, Zsuzsanna
AU - Greenberg, Mark
AU - von der Weid, Nicolas
AU - Kuehni, Claudia
AU - Zurriaga, Oscar
AU - Vicente, Maria-Luisa
AU - Peris-Bonet, Rafael
AU - Benesch, Martin
AU - Vekemans, Michel
AU - Sullivan, Sheena G
AU - Rickert, Christian
PY - 2013/3/1
Y1 - 2013/3/1
N2 - Persons with Down syndrome (DS) uniquely have an increased frequency of leukemias but a decreased total frequency of solid tumors. The distribution and frequency of specific types of brain tumors have never been studied in DS. We evaluated the frequency of primary neural cell embryonal tumors and gliomas in a large international data set. The observed number of children with DS having a medulloblastoma, central nervous system primitive neuroectodermal tumor (CNS-PNET) or glial tumor was compared to the expected number. Data were collected from cancer registries or brain tumor registries in 13 countries of Europe, America, Asia and Oceania. The number of DS children with each category of tumor was treated as a Poisson variable with mean equal to 0.000884 times the total number of registrations in that category. Among 8,043 neural cell embryonal tumors (6,882 medulloblastomas and 1,161 CNS-PNETs), only one patient with medulloblastoma had DS, while 7.11 children in total and 6.08 with medulloblastoma were expected to have DS. (p 0.016 and 0.0066 respectively). Among 13,797 children with glioma, 10 had DS, whereas 12.2 were expected. Children with DS appear to be specifically protected against primary neural cell embryonal tumors of the CNS, whereas gliomas occur at the same frequency as in the general population. A similar protection against neuroblastoma, the principal extracranial neural cell embryonal tumor, has been observed in children with DS. Additional genetic material on the supernumerary chromosome 21 may protect against embryonal neural cell tumor development.
AB - Persons with Down syndrome (DS) uniquely have an increased frequency of leukemias but a decreased total frequency of solid tumors. The distribution and frequency of specific types of brain tumors have never been studied in DS. We evaluated the frequency of primary neural cell embryonal tumors and gliomas in a large international data set. The observed number of children with DS having a medulloblastoma, central nervous system primitive neuroectodermal tumor (CNS-PNET) or glial tumor was compared to the expected number. Data were collected from cancer registries or brain tumor registries in 13 countries of Europe, America, Asia and Oceania. The number of DS children with each category of tumor was treated as a Poisson variable with mean equal to 0.000884 times the total number of registrations in that category. Among 8,043 neural cell embryonal tumors (6,882 medulloblastomas and 1,161 CNS-PNETs), only one patient with medulloblastoma had DS, while 7.11 children in total and 6.08 with medulloblastoma were expected to have DS. (p 0.016 and 0.0066 respectively). Among 13,797 children with glioma, 10 had DS, whereas 12.2 were expected. Children with DS appear to be specifically protected against primary neural cell embryonal tumors of the CNS, whereas gliomas occur at the same frequency as in the general population. A similar protection against neuroblastoma, the principal extracranial neural cell embryonal tumor, has been observed in children with DS. Additional genetic material on the supernumerary chromosome 21 may protect against embryonal neural cell tumor development.
KW - Cerebellar Neoplasms
KW - Child
KW - Child, Preschool
KW - Down Syndrome
KW - Female
KW - Humans
KW - Male
KW - Medulloblastoma
KW - World Health
U2 - 10.1007/s11060-012-1041-y
DO - 10.1007/s11060-012-1041-y
M3 - SCORING: Journal article
C2 - 23307327
VL - 112
SP - 107
EP - 114
JO - J NEURO-ONCOL
JF - J NEURO-ONCOL
SN - 0167-594X
IS - 1
ER -